electroCore, Inc. (NasdaqCM: ECOR)
Health Care · Health Care Equipment & Supplies · US
$10.52
+5.52% today · +99.6% 1Y
electroCore, Inc. (NasdaqCM: ECOR) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $94.85M and employs 83 people.
Over the last twelve months the share price has gained 99.6%, trading between 4.41 and 10.95.
Tweenvest scores electroCore, Inc. across four factors: quality 37/100, value 69/100, growth 100/100. Its strongest factor is growth.
ECOR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $94.85M
- Revenue (TTM)
- $36.97M
- P/E
- —
- EPS
- -1.66
- Dividend yield
- —
- Beta (5Y)
- 0.94
- 52-week high
- $10.95
- 52-week low
- $4.41
- Avg volume (3M)
- —
- Shares outstanding
- 9.02M
- Employees
- 83
- Next earnings
- —
About electroCore, Inc.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
- ISIN
- US28531P2020
- Founded
- 2005
- Listed since
- Jun 22, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.